Also found in: Medical.


 (bā′tə-ăg′ə-nĭst, bē′-)
An agent, such as albuterol, that stimulates beta-receptors in the autonomic nervous system.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Only 10% voted to keep the patient on the LAMA, and add a long-acting beta-agonist (LABA).
Dulohery Scrodin said was optimal; to keep the patient on the LAMA, and add a long-acting beta-agonist (LABA).
For patients not well controlled on low-dose ICSs, the dose can be increased or a long-acting beta-agonist (LABA) or leukotriene receptor antagonist (LTRA) can be added.
manufacturers sell to customers that require verification that the meat is derived from animals that were never fed beta-agonists, and is free of beta-agonist residues.
It is produced under a USDA Process Verification Program that ensures no beta-agonist growth promotants.
Intermittent asthma is categorized by less than 2 episodes of respiratory symptoms requiring the use of a rescue/short-acting beta-agonist inhaler per week.
The compounds or a control substance were combined and administered with the beta-agonist bronchodilator drug isoproterenol.
Breo Ellipta contains the corticosteroid fluticasone furoate, as well as vilanterol, a long-acting beta-agonist (LABA).
Beta-agonist and hormone bans in beef and beta-agonist bans in pork by the EU stem from the application of the so-called "precautionary principle," which it has used to justify bans and restrictions on a number of agricultural production technologies.
Although, the EU ban on beta-agonists is still in place, the European Food Safety Agency's recent positive opinion concerning Elanco's own Ractopamine beta-agonist product Paylean is viewed by Simmons as a good step in the pro-technology direction.
Inhaled corticosteroids and long-acting beta-agonist bronchodilators may be safer options.
Mike Ward of Ambrian Partners said the approval bar for new drugs containing a long-acting beta-agonist (LABA), like Advair, had also effectively been raised by a recent furor over LABA safety.

Full browser ?